Type II Diabetes Mellitus. Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients with at least 2 years of type 2 DM Using oral hypoglycemic agents but not insulin Fasting blood sugar (FBS) 150-200 mg/dl and HbA1c 7.5-9% Age between 40 and 60 years
Exclusion criteria
Exclusion criteria: unwillingness to participation; Pregnancy and lactation and in women of childbearing age without reliable contraceptive methods; Tobacco smokers and alcohol consumers and patients who tend to change their diet or exercise program. Any serious comorbidities (including renal failure, chronic hepatic failure, untreated heart failure, pulmonary infections and proliferative retinopathy), active neoplastic disease, a history of cancer less than 5 years, and depression
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood Suger. Timepoint: At the beginning and the end of study (60th day). Method of measurement: Lab Kit.;Lipid Profile. Timepoint: At the beginning and the end of study (60th day). Method of measurement: Lab Kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| HOMA-IR. Timepoint: At the beginnings and the end of study (90th day). Method of measurement: Lab Kit and Software calculation.;Hb A1C. Timepoint: At the beginnings and the end of study (90th day). Method of measurement: Lab kit.;Body Mass Index. Timepoint: At the beginnings and the end of study (90th day). Method of measurement: Scales and tape measure.;C reactive Protoein. Timepoint: At the beginnings and the end of study (90th day). Method of measurement: lab kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Maragheh University of Medical Sciences